Back
Oncternal Therapeutics Stock Price Chart
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
3
ONCT
Oncternal Therapeutics
Last Price:
1.70
Seasonality Move:
5.35%
7 Day Trial
ALL ACCESS PASS
$
7
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ONCT is experiencing slight buying pressure.
Oncternal Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.52 | Sell |
| 20-day SMA: | 3.61 | Sell |
| 50-day SMA: | 5.08 | Sell |
| 200-day SMA: | 7.77 | Sell |
| 8-day EMA: | 2.3 | Sell |
| 20-day EMA: | 3.3 | Sell |
| 50-day EMA: | 4.73 | Sell |
| 200-day EMA: | 7.26 | Sell |
Oncternal Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.95 | Sell |
| Relative Strength Index (14 RSI): | 21.44 | Sell |
| Chaikin Money Flow: | 52731 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.59 - 4.81) | Sell |
| Bollinger Bands (100): | (4.62 - 8.82) | Sell |
Oncternal Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Oncternal Therapeutics Stock
Is Oncternal Therapeutics Stock a Buy?
- Oncternal Therapeutics share price is 1.69 while ONCT 8-day simple moving average is 2.52, which is a Sell signal.
- The stock price of ONCT is 1.69 while Oncternal Therapeutics 20-day SMA is 3.61, which makes it a Sell.
- Oncternal Therapeutics 50-day simple moving average is 5.08 while ONCT share price is 1.69, making it a Sell technically.
- ONCT stock price is 1.69 and Oncternal Therapeutics 200-day simple moving average is 7.77, creating a Sell signal.
ONCT Technical Analysis vs Fundamental Analysis
Sell
3
Oncternal Therapeutics (ONCT)
is a Sell
Is Oncternal Therapeutics a Buy or a Sell?
-
Oncternal Therapeutics stock is rated a Sell
The current Oncternal Therapeutics [ONCT] share price is $1.69. The Score for ONCT is 3, which is 94% below its historic median score of 50, and infers higher risk than normal.
Oncternal Therapeutics Stock Info
Market Cap:
5M
Price in USD:
1.69
Share Volume:
168.62K
Oncternal Therapeutics 52-Week Range
52-Week High:
13.14
52-Week Low:
1.32
Sell
3
Oncternal Therapeutics (ONCT)
is a Sell
Oncternal Therapeutics Share Price Forecast
-
What is the Oncternal Therapeutics stock price today?
The Oncternal Therapeutics stock price is 1.69 USD today. -
Will ONCT stock go up or go down?
Oncternal Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Oncternal Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Oncternal Therapeutics is overvalued.
Is Oncternal Therapeutics Stock a Buy?
- Oncternal Therapeutics share price is 1.69 while ONCT 8-day exponential moving average is 2.30, which is a Sell signal.
- The stock price of ONCT is 1.69 while Oncternal Therapeutics 20-day EMA is 3.30, which makes it a Sell.
- Oncternal Therapeutics 50-day exponential moving average is 4.73 while ONCT share price is 1.69, making it a Sell technically.
- ONCT stock price is 1.69 and Oncternal Therapeutics 200-day simple moving average is 7.26, creating a Sell signal.
Fundamental Analysis of Oncternal Therapeutics
Is Oncternal Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $1.11 per share, an increase this year of $2.00 per share, and an increase next year of $2.22 per share.
Technical Analysis of Oncternal Therapeutics
Should I short Oncternal Therapeutics stock?
- ONCT Moving Average Covergence Divergence (MACD) indicator is -0.95, suggesting Oncternal Therapeutics is a Sell
- Oncternal Therapeutics Relative Strength Index (RSI) is 21.44, which suggest Oncternal Therapeutics is oversold
- The Bollinger Bands (25) for Oncternal Therapeutics is (2.59 - 4.81), which suggest Oncternal Therapeutics is a Sell
- The Bollinger Bands (100) for Oncternal Therapeutics is (4.62 - 8.82), which suggest Oncternal Therapeutics is a Sell
* Oncternal Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.